Desensitization treatment with cisplatin after carboplatin hypersensitivity reaction in gynecologic cancer

Journal of Medical Investigation

Volumn 57, Issue 1-2, 2010, Pages 163-167

  Abe, Akiko ^a   Ikawa, Hiroshi ^a   Ikawa, Saki ^a  

^a Tokushima Kouseiren Oe Kyodo Hosp   (Japan)

Author keywords

Carboplatin; Cisplatin; Desensitization; Hypersensitivity reactions

Indexed keywords

ADRENALIN; CA 125 ANTIGEN; CARBOPLATIN; CISPLATIN; DEXAMETHASONE; DOCETAXEL; GEMCITABINE; HYDROCORTISONE; PACLITAXEL; PROMETHAZINE; RANITIDINE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BRONCHOSPASM; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER REGRESSION; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; DESENSITIZATION; DISEASE COURSE; DRUG HYPERSENSITIVITY; DRUG INFUSION; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ENDOMETRIUM CANCER; ERYTHEMA; FEMALE; HUMAN; HYPERSENSITIVITY REACTION; ILEUS; INTERSTITIAL PNEUMONIA; LUNG METASTASIS; MONOTHERAPY; NAUSEA; OUTCOME ASSESSMENT; OVARY CANCER; OXYGEN SATURATION; PELVIS TUMOR; PRURITUS; RETREATMENT; SIDE EFFECT; TACHYCARDIA; THORAX PAIN; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; UTERINE CERVIX CANCER; WHEEZING;

EID: 77749298534     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.57.163     Document Type: Article

References (14)

1. Bois A, Lück HJ, Meier W, Adams HP, Möbus V, Costa S, Bauknecht T, Richter B, Warm M, Schröder W, Olbricht S, Nitz U, Jackisch C, Emons G, Wagner U, Kuhn W, Pfisterer J: A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer. J Natl Cancer Inst 95: 1320-1329, 2003
2. Lee CW, Matulonis UA, Castells MC: Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/ IgE-mediated reactions. Gynecol Oncol 95: 370-376, 2004
3. Markman M, Kennedy A, Webster K, Elson P, Peterson G, Kulp B, Belinson J: Clinical features of hypersensitivity reactions to carboplatin. J Clin Oncol 17: 1141-1145, 1999
4. Tara M, McElroy, Vivian E, von Gruenigen, Steven E, Waggoner: A case of prolonged carboplatin therapy in a patient with carboplatin hypersensitivity. Gynecol Oncol 91: 435-437, 2003
5. Robert J, Mary R, Michael F: Carboplatin hypersensitivity reactions: re-treatment with cisplatin desensitization Gynecol Oncol 89: 112-115, 2003
6. Callahan MB, Lachance JA, Stone RL, Kelsey J, Rice LW, Jazaeri AA: Use of cisplatin without desensitization after carboplatin hypersensitivity reaction in epithelial ovarian and primary peritoneal cancer. AJOG 197-199, 2007
7. Koshiba H, Hosokawa K, Kudo A, Miyagi Y, Oda T, Miyagi Y, Watanabe A, Honjo H: Incidence of carboplatin-related hypersensitivity reactions in Japanese patients with gynecologic malignancies. Int J Gynecol Cancer 19: 460-465, 2009
8. Windom HH, McGuire WP 3rd, Hamilton RG, Adkinson NF Jr: Anaphylaxis to carboplatin - a new platinum chemotherapeutic agent. J Allergy Clin Immunol 90: 681-683, 1992
9. Zanotti KM, Rybicki LA, Kennedy AW, Belinson JL, Webster KD, Kulp B, Markman M: Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy. J Clin Oncol 15: 3126-3129, 2001
10. Shukunami K, Kurosawa T, Kubo M, Kaneshima M, Kimitani N, Kotsuji F: Hypersensitivity reaction to carboplatin during treatment for ovarian cancer. Tumori 85: 297-298, 1998
11. Ottaiano A, Tambaro R, Greggi S, Prato R, Esposito, Dimaio M, Esposito G, Scala F, Barletta E, Losito S, Vivo RD, Losito S, Vivo RD, Iaffaioli VR, Pignata S: Safety of cisplatin after severe hypersensitivity reactions to carboplatin in patients with recurrent ovarian carcinoma. Anticancer Res 23: 3465-3468, 2003
12. Castells MC, Tennant NM, Sloane DE, Hsu FI, Barrett NA, Hong DI, Laidlaw TM, Legere HJ, Nallamshetty SN, Palis RI, Rao JJ, Berlin ST, Campos SM, Matulonis UA: J Allergy Clin Immunol 122: 574-580, 2008
13. Polyzos A, Tsavaris N, Kosmas C, Arnaouti T, Kalahanis N, Tsigris C, Giannopoulos A, Karatzas G, Giannikos L, Sfikakis PP: Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience. Oncology 61: 129-133, 2001
14. Fujiwara K, Markman M, Morgan M, Coleman RL: Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancer. Gynecol Oncol 97: 10-15, 2005